Tuo YL - Search Results

1

Erratum to: The Role of CARD9 in Metabolic Diseases.

Tian C, Tuo YL, Lu Y, Xu CR, Xiang M. Tian C, et al. Among authors: tuo yl. Curr Med Sci. 2020 Jun;40(3):595. doi: 10.1007/s11596-020-2219-8. Curr Med Sci. 2020. PMID: 32681266 Free PMC article.

2

Effects of kinsenoside, a potential immunosuppressive drug for autoimmune hepatitis, on dendritic cells/CD8⁺ T cells communication in mice.

Xiang M, Liu T, Tan W, Ren H, Li H, Liu J, Cao H, Cheng Q, Liu X, Zhu H, Tuo Y, Wang J, Zhang Y. Xiang M, et al. Hepatology. 2016 Dec;64(6):2135-2150. doi: 10.1002/hep.28825. Epub 2016 Oct 28. Hepatology. 2016. PMID: 27639182

3

Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis.

Cao H, Tuo L, Tuo Y, Xia Z, Fu R, Liu Y, Quan Y, Liu J, Yu Z, Xiang M. Cao H, et al. Front Pharmacol. 2017 Jul 7;8:445. doi: 10.3389/fphar.2017.00445. eCollection 2017. Front Pharmacol. 2017. PMID: 28736524 Free PMC article.

4

Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression.

Liu X, Zhou Z, Cheng Q, Wang H, Cao H, Xu Q, Tuo Y, Jiang L, Zou Y, Ren H, Xiang M. Liu X, et al. Cell Death Dis. 2017 Sep 7;8(9):e3033. doi: 10.1038/cddis.2017.424. Cell Death Dis. 2017. PMID: 28880262 Free PMC article.

5

mTOR: A double-edged sword for diabetes.

Tuo Y, Xiang M. Tuo Y, et al. J Leukoc Biol. 2018 Jan 9. doi: 10.1189/JLB.3MR0317-095RR. Online ahead of print. J Leukoc Biol. 2018. PMID: 29345360 Review.

6

mTOR: A double-edged sword for diabetes.

Tuo Y, Xiang M. Tuo Y, et al. J Leukoc Biol. 2019 Aug;106(2):385-395. doi: 10.1002/JLB.3MR0317-095RR. Epub 2018 Mar 26. J Leukoc Biol. 2019. PMID: 29578634 Review.

7

Cassiabudanols A and B, Immunostimulative Diterpenoids with a Cassiabudane Carbon Skeleton Featuring a 3-Oxatetracyclo[6.6.1.0^2,6.0^10,14]pentadecane Scaffold from Cassia Buds.

Zhou H, Guoruoluo Y, Tuo Y, Zhou J, Zhang H, Wang W, Xiang M, Aisa HA, Yao G. Zhou H, et al. Org Lett. 2019 Jan 18;21(2):549-553. doi: 10.1021/acs.orglett.8b03883. Epub 2019 Jan 2. Org Lett. 2019. PMID: 30601013

8

Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.

Tuo Y, Zhang Z, Tian C, Hu Q, Xie R, Yang J, Zhou H, Lu L, Xiang M. Tuo Y, et al. J Leukoc Biol. 2020 Jul;108(1):215-228. doi: 10.1002/JLB.3MA0120-578R. Epub 2020 Jan 29. J Leukoc Biol. 2020. PMID: 31994797

9

The Role of CARD9 in Metabolic Diseases.

Tian C, Tuo YL, Lu Y, Xu CR, Xiang M. Tian C, et al. Among authors: tuo yl. Curr Med Sci. 2020 Apr;40(2):199-205. doi: 10.1007/s11596-020-2166-4. Epub 2020 Apr 26. Curr Med Sci. 2020. PMID: 32337681 Review.

10

The paradoxical role of methionine enkephalin in tumor responses.

Tuo Y, Tian C, Lu L, Xiang M. Tuo Y, et al. Eur J Pharmacol. 2020 Sep 5;882:173253. doi: 10.1016/j.ejphar.2020.173253. Epub 2020 Jun 11. Eur J Pharmacol. 2020. PMID: 32535097 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page